https://www.avient.com/industries/healthcare/medical-packaging/diagnostic-kits
Explore how Avient Healthcare Polymer Colorant and Additive Solutions can support the growing healthcare market trends by helping our customers to manage product performance and risk.
Learn how Mevopur™ Healthcare Functional Additives help protect and enhance the performance of polymers used in healthcare applications
https://www.avient.com/products/engineered-polymer-formulations/sustainable-formulations/nymax-rec-recycled-nylon-formulations
Explore how to take weight out of your products and improve the ergonomics and fuel efficiency.
Learn how Nymax™ REC nylon grade with PIR content improved a holster for a military and tactical gear manufacturer
https://www.avient.com/products/engineered-polymer-formulations/general-engineered-formulations/edgetek-engineered-polymer-formulations
Discover how to choose the best filler or reinforcement for your application needs.
Discover how Avient can help you develop and build nearly any automotive part you need to create.
https://www.avient.com/industries/healthcare/labware-diagnostics/laboratory-equipment
Explore how Trilliant™ conductive formulations help solve the performance challenges for pipette tip applications
Explore how Trilliant™ conductive formulations help solve the performance challenges for pipette tip applications (Chinese language version)
https://www.avient.com/industries/healthcare/remote-monitoring-wearables/continuous-glucose-monitors-cgm
Learn how Mevopur™ Healthcare Functional Additives help protect and enhance the performance of polymers used in healthcare applications
Learn how Mevopur™ Healthcare Functional Additives help protect and enhance the performance of polymers used in healthcare applications (Chinese language version)
https://www.avient.com/industries/healthcare/drug-delivery-systems/auto-injectors-and-drug-delivery-pens
Learn how chemically resistant Trilliant™ HC thermoplastics and Versaflex™ HC TPEs provide enhanced durability to withstand common hospital cleaners and disinfectants
Learn how Mevopur™ Healthcare Functional Additives help protect and enhance the performance of polymers used in healthcare applications
https://www.avient.com/products/thermoplastic-elastomers/onflex-thermoplastic-elastomers
Discover how Avient can help you develop and build nearly any automotive part you need to create.
Read how the combined value of a specialty TPE and technical support met processing and performance demands
https://www.avient.com/news/avient-joint-study-borealis-reveals-wide-range-color-options-recycled-plastics
Bridging from the EverMinds™ platform, Borealis and Avient recently completed a joint application study investigating how to optimize color matching when using post-consumer recycled material (PCR) in rigid packaging applications.
This collaborative study with Borealis is one way in which we can transfer our know-how to our value chain partners to help with closing the loop on plastics circularity.”
https://www.avient.com/investor-center/news/polyone-signs-definitive-agreement-acquire-clariant-color-and-additive-masterbatch-business
color and additive masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisition and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Morgan%2520Stanley%2520Conference.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• The ability to successfully integrate acquired companies into our operations, retain the management teams of acquired companies, retain
relationships with customers of acquired companies, and achieve the expected results of such acquisitions, including whether such
businesses will be accretive to our earnings;
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the
availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• Changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic in jurisdictions where we
conduct business;
• Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;
• Fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated
with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• Information systems failures and cyber attacks; and
• Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in
interest rates and changes in the rate of inflation.
1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from
personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation
costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or
disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; the effect of changes in accounting principles or other
such laws or provisions affecting reported results and tax adjustments.
Tax adjustments include the net tax (expense) benefit from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuation allowance
adjustments.
2
Adjusted EBITDA and net debt to adjusted EBITDA is calculated as follows:
(In millions)
Year Ended December
31, 2017
Income from continuing operations, before income taxes $ 212.3
Interest expense, net 60.8
Depreciation and amortization 82.8
Special items impact on income from continuing operations, before income taxes(1) 32.9
Adjusted EBITDA $ 388.8
Senior secured revolving credit facility $ 56.5
Senior secured term loan due 2022 637.5
Total Secured Debt 694.0
Less: Cash and cash equivalents (243.6)
Net Secured Debt $ 450.4
Short-term and current portion of long-term debt $ 32.6
Long-term debt 1,290.9
Total Debt 1,323.5
Less: Cash and cash equivalents (243.6)
Net Debt $ 1,079.9
Total Secured Debt / Adjusted EBITDA 1.8
Net Secured Debt / Adjusted EBITDA 1.2
Total Debt / Adjusted EBITDA 3.4
Net Debt / Adjusted EBITDA 2.8
(1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs
resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans;
environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and
losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; the effect of
changes in accounting principles or other such laws or provisions affecting reported results and tax adjustments.